Immunopharmacology

Plasma and tissue kallikrein in arthritis and inflammatory bowel disease
pp. 103-108(6)
Author: Colman R.W.

Activation of the plasma kallikrein/kinin system on endothelial cell membranes
pp. 109-114(6)
Authors: Rojkjaer R.; Schmaier A.H.

Kallikrein-kinin in infection and cancer
pp. 115-128(14)
Authors: Maeda H.; Wu J.; Okamoto T.; Maruo K.; Akaike T.

Altered cardiac tissue and plasma kininogen levels in hypertensive and diabetic rats
pp. 129-132(4)
Authors: Sharma J.N.; Kesavarao U.; Yusof A.P.M.

The relationship between the onset of labor mechanisms and the hemostatic system
pp. 133-140(8)
Authors: Suzuki S.; Morishita S.

Effects of the propofol combination anesthesia on the intrinsic blood-clotting system
pp. 141-144(4)
Authors: Schulze H.-J.; Wendel H.P.; Kleinhans M.; Oehmichen S.; Heller W.; Elert O.

Cardiopulmonary bypass increases plasma bradykinin concentrations
pp. 145-147(3)
Authors: Cugno M.; Nussberger J.; Biglioli P.; Giovagnoni M.G.; Gardinali M.; Agostoni A.

Increased adsorption of high molecular weight kininogen to heparin-coated artificial surfaces and correlation to hemocompatibility
pp. 149-153(5)
Authors: Wendel H.P.; Weber N.; Ziemer G.

Bradykinin antagonists: present progress and future prospects
pp. 155-161(7)
Authors: Stewart J.M.; Gera L.; York E.J.; Chan D.C.; Bunn P.

Discovery of orally active nonpeptide bradykinin B₂ receptor antagonists
pp. 163-168(6)
Authors: Asano M.; Inamura N.; Hatori C.; Sawai H.; Fujiwara T.; Abe Y.; Kayakiri H.; Satoh S.; Oku T.; Nakahara K.

Small molecule antagonists of the bradykinin B1 receptor
pp. 169-177(9)
Authors: Horlick R.A.; Ohlmeyer M.H.; Stroke I.L.; Strohl B.; Pan G.; Schilling A.E.; Paradkar V.; Quintero J.G.; You M.; Riviello C.; Thorn M.B.; Damaj B.; Fitzpatrick V.D.; Dolle R.E.; Webb M.L.; Baldwin J.J.; Sigal N.H.

Characterization of non-peptide bradykinin B₂ receptor agonist (FR 190997) and antagonist (FR 173657)
pp. 179-185(7)
Authors: Gobeil F.; Montagne M.; Inamura N.; Regoli D.

Pharmacological profile of LF 16-0687, a new potent non-peptide bradykinin B₂ receptor antagonist
pp. 187-194(8)
Authors: Pruneau D.; Paquet J.L.; Luccarini J.M.; Defrene E.; Fouchet C.; Franck R.-M.; Loillier B.; Robert C.; Belichard P.; Duclos H.; Cremers B.; Dodey P.

5-Hydroxytryptamine release from skin mast cells in vivo induced by peptide but not by nonpeptide ligands for bradykinin receptors
pp. 195-201(7)
Authors: Griesbacher T.; Rainer I.

Interaction of Factor XII and high molecular weight kininogen with cytokeratin 1 and gC1qR of vascular endothelial cells and with aggregated A protein of Alzheimer's disease
pp. 203-210(8)
Authors: Joseph K.; Shibayama Y.; Nakazawa Y.; Peerschke E.I.B.; Ghebrehiwet B.; Kaplan A.P.

Hydrolysis of kininogens by degranulated human neutrophils and analysis of bradykinin as chemotactic factor for cells isolated from peripheral blood
pp. 211-217(7)
Authors: Figueroa C.D.; Stuardo M.; Gonzalez C.B.; Nualart F.; Corthorn J.; Boric M.; Bhoola K.D.

Inhibition of kinin action and kinin generation compared to dexamethasone pretreatment with respect to vascular effects and pancreatic enzymes in experimental acute pancreatitis
pp. 219-224(6)
Authors: Griesbacher T.; Rainer I.; Evans D.M.

Correlation of kinin generating activity with Helicobacter pylori-associated gastric infection
pp. 225-233(9)
Authors: Naidoo S.; Ramsaroop R.; Bhoola R.; Bhoola K.

Induction of the bradykinin B2-receptor, but not of the bradykinin B1-receptor, by interleukin-1 in cultivated human decidua-derived cells
pp. 235-239(5)
Authors: Rehbock J.; Miska K.; Buchinger P.

Renal ischemia-induced increase in vascular permeability is limited by hypothermia
pp. 241-248(8)
Authors: Carattino M.D.; Cueva F.; Zuccollo A.; Monti J.L.; Navarro M.; Catanzaro O.L.

Bradykinin B₂ antagonist HOE 140 inhibits late allergic microvascular leakage in guinea pig airways
pp. 249-253(5)
Authors: Mashito Y.; Ichinose M.; Shirato K.

Kinin receptors are expressed in human astrocytic tumour cells
pp. 255-263(9)
Authors: Raidoo D.M.; Sawant S.; Mahabeer R.; Bhoola K.D.

Rhesus differential susceptibility to endotoxin is not associated with activation of plasma prekallikrein
pp. 265-271(7)
Authors: Veloso D.; Smith J.I.; Cosgriff T.M.

The possible role of plasma kallikrein-kinin system and leukocyte elastase in pathogenesis of schizophrenia
pp. 273-279(7)
Authors: Shcherbakova I.; Neshkova E.; Dotsenko V.; Platonova T.; Shcherbakova E.; Yarovaya G.

The effect of high molecular weight kininogen on neutrophil adhesion to polymer surfaces
pp. 281-286(6)
Authors: Yung L.-Y.L.; Colman R.W.; Cooper S.L.

Identification and occurrence of mRNAs for components of the kallikrein-kinin system in human skin and in skin diseases
pp. 287-291(5)
Authors: Schremmer-Danninger E.; Hermann A.; Fink E.; Fritz H.; Roscher A.A.

Serum metabolism of bradykinin and des-Arg⁹-bradykinin in patients with angiotensin-converting enzyme inhibitor-associated angioedema
pp. 293-302(10)
Authors: Blais C.; Rouleau J.-L.; Brown N.J.; Lepage Y.; Spence D.; Munoz C.; Friborg J.; Geadah D.; Gervais N.; Adam A.

Visualisation of tissue kallikrein and kinin receptors in oesophageal carcinoma
pp. 303-310(8)
Authors: Dlamini Z.; Raidoo D.; Bhoola K.

Anti-inflammatory activity of Crinum asiaticum plant and its effect on bradykinin-induced contractions on isolated uterus
pp. 311-316(6)
Authors: Samud A.M.; Asmawi M.Z.; Sharma J.N.; Yusof A.P.M.